Resino, S.; Fernández-Rodríguez, A.; Pineda-Tenor, D.; Gómez-Moreno, A.Z.; Sánchez-Ruano, J.J.; Artaza-Varasa, T.; Muñoz-Gómez, M.J.; Virseda-Berdices, A.; Martín-Vicente, M.; Martínez, I.;
et al. TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients. J. Clin. Med. 2021, 10, 483.
https://doi.org/10.3390/jcm10030483
AMA Style
Resino S, Fernández-Rodríguez A, Pineda-Tenor D, Gómez-Moreno AZ, Sánchez-Ruano JJ, Artaza-Varasa T, Muñoz-Gómez MJ, Virseda-Berdices A, Martín-Vicente M, Martínez I,
et al. TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients. Journal of Clinical Medicine. 2021; 10(3):483.
https://doi.org/10.3390/jcm10030483
Chicago/Turabian Style
Resino, Salvador, Amanda Fernández-Rodríguez, Daniel Pineda-Tenor, Ana Zaida Gómez-Moreno, Juan José Sánchez-Ruano, Tomas Artaza-Varasa, María José Muñoz-Gómez, Ana Virseda-Berdices, María Martín-Vicente, Isidoro Martínez,
and et al. 2021. "TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients" Journal of Clinical Medicine 10, no. 3: 483.
https://doi.org/10.3390/jcm10030483
APA Style
Resino, S., Fernández-Rodríguez, A., Pineda-Tenor, D., Gómez-Moreno, A. Z., Sánchez-Ruano, J. J., Artaza-Varasa, T., Muñoz-Gómez, M. J., Virseda-Berdices, A., Martín-Vicente, M., Martínez, I., & Jiménez-Sousa, M. A.
(2021). TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients. Journal of Clinical Medicine, 10(3), 483.
https://doi.org/10.3390/jcm10030483